Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Recruiting now

Conditions studied: Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation

In brief

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Key facts

Study ID

NCT07140757

Run by

M.D. Anderson Cancer Center

People needed

50

Starts

2025-08-18

Expected to finish

2030-12-31

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Participants meeting any of the following criteria will be excluded:
• Participants considered unsuitable for RFA by the treating physician

Where it is running

• MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.